AMBU A/S: Financial statements 2014
CVR: 63644919
Source: annual report 2014, Danish Business Authority
01/10/2013 – 30/09/2014
AMBU A/S (CVR 63644919) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 1,584,000,000 and a net result of DKK 151,000,000. The profit margin was 9.5%. Equity in the 2014 report amounted to DKK 854,000,000. The solvency ratio was 41.7%.
- Revenue
- DKK 1,584,000,000
- Gross Profit
- DKK 798,000,000
- Profit/Loss
- DKK 151,000,000
- Equity
- DKK 854,000,000
- Total Assets
- DKK 2,047,000,000
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
AMBU A/S has published its interim report for the period April 1, 2014 – June 30, 2014.
AMBU A/S has published its interim report for the period October 1, 2013 – March 31, 2014.
AMBU A/S has published its interim report for the period October 1, 2013 – December 31, 2013.
AMBU A/S has published its annual report for 2013.
About AMBU A/S
AMBU A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1956. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named AMBU INTERNATIONAL A/S and TESTA-LABORATORIUM A/S. The management consists of Britt Meelby Jensen and Henrik Skak Bender. The board consists of Jørgen Falkebo Jensen (chair), Shacey Marie Petrovic, David Lippincott Hale and Eva Marie Susanne Larsson. The company's owners include Anne-Mette Ragle, Pia Hesse and Kim Ragle. The company has 223 employees (2018). In 2025, the company reported revenue of DKK 6,037,000,000 and a net result of DKK 609,000,000 compared with DKK 235,000,000 the year before. Equity in the 2025 report amounted to DKK 6,035,000,000.